...
首页> 外文期刊>Comparative Immunology, Microbiology and Infectious Diseases >Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine
【24h】

Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine

机译:封装在壳聚糖纳米颗粒中的猪白细胞介素2基因增强小鼠对仔猪副伤寒疫苗的免疫反应

获取原文
获取原文并翻译 | 示例
           

摘要

Interleukin-2 (IL-2) is vital to elicit and amplify the cellular and humoral immune responses to foreign antigens, which is extensively utilized in the control of infectious disease and treatment of various cancers. Porcine and murine IL-2 genes were, respectively, subcloned into VR1020, designated as VPIL-2 and VMIL-2, and then encapsulated in chitosan nanoparticles (CNP) prepared by ionic linkage. The BALB/c mice were intramuscularly co-administrated with chitosan-IL-2 nanoparticles (CNP-IL2) and paratyphoid vaccine to test the adjuvant effect of CNP-IL2. On day 35, the immunized mice were orally challenged with virulent Salmonella. The content of IgG, IgA, IgM, IL-2, IL-4, IL-6 and specific antibody titer as well as the number of immunocompetent cells were systematically analyzed in the vaccinated mice. The results revealed that the levels of immunoglobulins, cytokines, the specific antibodies, together with the numbers of lymphocytes significantly increased in vaccinated mice inoculated with CNP-VPIL2 in contrast with those with naked IL-2 plasmids and blank plasmids. The CNP-VPIL2 immunized mice exhibited higher humoral and cellular immune responses, less severe clinical signs and lesions of disease caused by the bacteria than the other groups after challenge. These findings suggest that CNP-VPIL2 has a significant enhancement effect on immune responses of mice, which results in better immunoprotection against Salmonella infection, indicating that CNP-VPIL2 could be employed as an effective immunoadjuvant to elevate immunity of animals to conventional vaccines.
机译:白细胞介素-2(IL-2)对于引发和增强针对外来抗原的细胞和体液免疫反应至关重要,该反应已广泛用于控制传染病和治疗各种癌症。将猪和鼠的IL-2基因分别亚克隆到VR1020中,分别命名为VPIL-2和VMIL-2,然后将其封装在通过离子键合制备的壳聚糖纳米颗粒(CNP)中。将BALB / c小鼠与壳聚糖-IL-2纳米颗粒(CNP-IL2)和副伤寒疫苗肌肉内联合给药,以测试CNP-IL2的佐剂作用。在第35天,用强毒沙门氏菌对经免疫的小鼠进行口服攻击。系统地分析了接种小鼠的IgG,IgA,IgM,IL-2,IL-4,IL-6和特异性抗体滴度以及免疫活性细胞的数量。结果表明,与裸IL-2质粒和空白质粒相比,接种CNP-VPIL2的疫苗接种小鼠的免疫球蛋白,细胞因子,特异性抗体水平以及淋巴细胞数量显着增加。攻击后,经CNP-VPIL2免疫的小鼠表现出更高的体液和细胞免疫反应,较轻的临床症状和由细菌引起的疾病损害。这些发现表明CNP-VPIL2对小鼠的免疫反应具有显着的增强作用,从而导致针对沙门氏菌感染的更好的免疫保护,表明CNP-VPIL2可以用作有效的免疫佐剂,以提高动物对常规疫苗的免疫力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号